The association between Medicare Advantage market penetration and diabetes in the United States.

Frontiers in Public Health

Faizan M. Casim¹  Stephanie Lazarus Bernell²  Zidong eZhang³  Steven W. Howard³  Jennifer eWilmott³  Jing eWang³  Lindsey ePearson⁴  Caitlin eByler⁵ 

[1] HealthCom Research;Oregon State University;Saint Louis University;St. Luke's Health System - Kansas City;University of Texas MD Anderson Cancer Center;

关键词: cardiovascular disease;    diabetes;    MEPS;    Market penetration;    Spill-over effects;    Medicare Advantage;   

DOI  :  10.3389/fpubh.2015.00229

来源: DOAJ

【 摘 要 】

The objective of this study is to explore the extent to which managed care market penetration in the U.S. is associated with the presence of chronic disease. Diabetes was selected as the chronic disease of interest due to its increasing prevalence as well as the disease management protocols that can lessen disease complications.We hypothesized that greater managed care market penetration would be associated with: 1) lower prevalence of diabetes, and 2) lower prevalence of diabetes-related comorbidities among diabetics.Data for this analysis came from two sources.We merged Medicare Advantage (MA) market penetration data from the Centers for Medicare and Medicaid Services (CMS) with data from the Medical Expenditure Panel Survey (MEPS) (2004 to 2008).Results suggest that county-level MA market penetration is not significantly associated with prevalence of diabetes or diabetes-related comorbidities.That finding is quite interesting in that managed care market penetration has been shown to have an effect on utilization of inpatient services.It may be that managed care protocols do not offer the same benefits beyond the inpatient setting.

【 授权许可】

Unknown